Rspondins As Modulators Of Angiogenesis And Vasculogenesis

Patent No. EP2081586 (titled "Rspondins As Modulators Of Angiogenesis And Vasculogenesis") was filed by Deutsches Krebsforschungszentrum on Oct 19, 2007. The application was issued on Oct 31, 2018.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
PREDAZZISep 23, 2016MATHYS & SQUIRE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2081586

DEUTSCHES KREBSFORSCHUNGSZENTRUM
Application Number
EP07819170A
Filing Date
Oct 19, 2007
Status
Patent Maintained As Amended
Sep 28, 2018
Publication Date
Oct 31, 2018